BIAF presented its test to health professionals and VA leaders under a distribution agreement. The filing reports no sales or patient use, so it does not show a change in the company's outlook.
The presentation may help more health workers learn about the test. But the filing reports no orders, sales, or patient use, so it does not show a change in the company's business outlook.
Follow bioAffinity Technologies, Inc. (BIAF) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIAF